Distinguished in Transient Ischemic Attack (TIA)

George C. Ntaios

Thessaloniki, ESYE12, GR 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Transient Ischemic Attack (TIA)
Thessaloniki, ESYE12, GR 
OverviewLocationsClinical Research

Overview

George Ntaios practices in Thessaloniki, Greece. Mr. Ntaios is rated as a Distinguished expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Stroke, Atrial Fibrillation, Patent Foramen Ovale, Thrombectomy, and Patent Foramen Ovale Repair.

His clinical research consists of co-authoring 288 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 32 articles in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Thessaloniki, ESYE12, Greece
Other Locations
Larisa, ESYE14, Greece
Athens, ESYE31 11528, Greece
ESYE14, Greece
Volos, ESYE14, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes- Stroke Units Necessity for Patients (SUN4P)
Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes- Stroke Units Necessity for Patients (SUN4P)
Enrollment Status: Completed
Publish Date: April 13, 2022
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Enrollment Status: Unknown
Publish Date: November 11, 2021
Prediction of Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source (AF-ESUS)
Prediction of Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source (AF-ESUS)
Enrollment Status: Unknown
Publish Date: October 17, 2018
View 4 Less Clinical Trials

288 Total Publications

Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.
Journal: European stroke journal
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ntaios's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile